BMJ-British Medical Journal, published by the esteemed BMJ PUBLISHING GROUP, is a leading academic journal in the field of medicine, specifically categorized within the top Tier Q1 in Medicine (miscellaneous) based on the 2023 rankings. Recognized for its significant impact, BMJ holds an impressive rank of #15 out of 636 in General Medicine, placing it in the 97th percentile among its peers. With a legacy dating back to 1857, this journal continues to foster critical discussions and disseminate high-quality research aimed at advancing clinical practice and healthcare policy. While currently not an open-access journal, its rigorous peer-review process ensures that every publication meets the highest standards of scientific integrity and relevance. Situated in the heart of London at the British Medical Association House, the BMJ remains an essential resource for researchers, healthcare professionals, and students alike, dedicated to sharing impactful findings and innovative medical insights.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, published by Elsevier Masson SAS Éditeur, is a distinguished journal dedicated to the field of medicine, specifically focusing on various aspects of medical research and advancements. With its inception dating back to 1947, this journal has served as a vital platform for the dissemination of scholarly articles, reviews, and case studies, contributing significantly to the knowledge base within the medical community. Although it is indexed in the Q4 category for medicine (miscellaneous) and has a Scopus rank of #444/636, the journal maintains a key role in promoting ongoing education and discussion among researchers and professionals. The journal does not currently offer Open Access options, allowing for a traditional subscription model that appeals to institutions and individuals seeking comprehensive resources. With a commitment to addressing contemporary medical dilemmas and fostering innovation, the BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE is an essential resource for scholars and practitioners aiming to stay abreast of the latest developments in the field.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

Canadian Journal of Bioethics-Revue Canadienne de Bioethique, published by the Universite de Montreal, is a premier open-access journal dedicated to advancing the multidisciplinary field of bioethics since 2012. Emphasizing the complexities of ethical practices in health policy, it serves as a vital resource for researchers, professionals, and students engaged in health and philosophy. With its E-ISSN 2561-4665, the journal's content is freely accessible, fostering knowledge dissemination and academic collaboration. Although categorized in Q4 among Health Policy and Health (social science) in 2023, it holds a respectable Q2 status in Philosophy, reflecting its strong theoretical contributions. Covering a wide scope from 2018 to 2024, the journal encourages robust discourse on pressing ethical issues facing contemporary healthcare systems. For those seeking to connect with the evolving narratives in bioethics, this journal is indispensable.

Ethics & Bioethics is a vital interdisciplinary journal published by DE GRUYTER POLAND SP Z O O, focusing on the ethical dimensions of biological and medical practices. Since its transition to an Open Access model in 2016, the journal has become more accessible, promoting the dissemination of high-quality research to a broader audience. Based in Warsaw, Poland, this journal contributes significantly to the discourse on ethical practices in health policy, education, and philosophy, as evidenced by its impressive Scopus rankings, including a Q1 quartile in Philosophy. Covering a wide spectrum of ethical issues and dilemmas faced in contemporary society, Ethics & Bioethics provides a platform for researchers, professionals, and students to engage with cutting-edge scholarship aimed at advancing understanding and fostering dialogue in the ever-evolving landscape of bioethics. With a commitment to rigorous peer review and academic integrity, this journal is pivotal for those seeking to enhance their knowledge and contribute to the field.

Medecine & Droit, an esteemed journal published by ELSEVIER MASSON, CORP OFF, serves as a vital resource for the intersection of law and medicine. Since its inception in 1995, this journal has facilitated scholarly discourse by publishing innovative research, case studies, and reviews that explore the complexities of legal frameworks impacting medical practice and public health. Although currently classified in the fourth quartile within both the Law and Medicine (miscellaneous) categories for 2023, its contributions are important for legal professionals and healthcare providers seeking to navigate the evolving landscape of medical laws. With an ISSN of 1246-7391 and E-ISSN 1873-6475, it provides essential insights and stimulates interdisciplinary collaboration within academia. Authors and researchers are encouraged to contribute and engage with critical topics shaping the future of medicine and law through this essential publication.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.